CryoPort has appointed Michael Bartholomew as the new chief commercialisation officer.
Prior to joining CryoPort, Bartholomew has worked with DDN Pharmaceutical Logistics as the vice president of Sales and Marketing, where he developed and launched several commercial initiatives that achieved sustained sales growth.
Before joining DDN, he was the vice president of Sales and Marketing at Alby Materials and a senior institutional sales manager for Pfizer.
CryoPort president and CEO Larry Stambaugh said that Bartholomew has an outstanding track record of achieving rapid sales growth and developing business opportunities in the life science industry.
“He has built high-performance sales organisations for several companies, and we are looking forward to having his knowledge and leadership skills at CryoPort,” Stambaugh said.